Thermo Fisher Scientific Inc (TMO) is a leading diagnostics & research business with stocks listed in the US. It opened the day at US$490.88 after a previous close of US$495.76. During the day the price has varied from a low of USD489.6 to a high of USD499.2. The latest price was USD496.13 (25 minute delay). Thermo Fisher Scientific is listed on the NYSE. All prices are listed in US Dollars.
Our top pick for
US stocks
Our top pick for
Low costs
Our top pick for
Dividend investing
Thermo Fisher Scientific's shares were split on a 3:2 basis on 6 June 1996. So if you had owned 2 shares the day before the split, the next day you would own 3 shares. This wouldn't directly have changed the overall worth of your Thermo Fisher Scientific shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Thermo Fisher Scientific shares which in turn could have impacted Thermo Fisher Scientific's share price.
| Open | US$490.88 |
|---|---|
| High | US$499.2 |
| Low | US$489.6 |
| Close | US$496.13 |
| Previous close | US$495.76 |
| Change | US$0.37 |
| Change % | 0.0746% |
| Volume | 1,207,086 |
| 52-week range | US$415.6 - US$608.6332 |
|---|---|
| 50-day moving average | US$476.546 |
| 200-day moving average | US$526.4117 |
| Target price | US$525.14 |
| PE ratio | 32.1612 |
| Dividend yield | US$1.35 (0.29%) |
| Earnings per share (TTM) | US$15.26 |
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Historical closes compared with the last close of $496.13
| 1 week (2023-11-24) | 1.09% |
|---|---|
| 1 month (2023-11-01) | 12.47% |
| 3 months (2023-09-01) | -10.96% |
| 6 months (2023-06-01) | -4.48% |
| 1 year (2022-12-01) | -12.12% |
|---|---|
| 2 years (2021-12-01) | -20.76% |
| 3 years (2020-12-02) | 3.60% |
| 5 years (2018-11-30) | 98.81% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Thermo Fisher Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thermo Fisher Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Thermo Fisher Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 32x. In other words, Thermo Fisher Scientific shares trade at around 32x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Thermo Fisher Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.2837. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Thermo Fisher Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Thermo Fisher Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$10.8 billion (£8.5 billion).
The EBITDA is a measure of a Thermo Fisher Scientific's overall financial performance and is widely used to measure a its profitability.
Over the last 12 months, Thermo Fisher Scientific's shares have ranged in value from as little as US$415.6 up to US$608.6332. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Thermo Fisher Scientific's is 0.813. This would suggest that Thermo Fisher Scientific's shares are less volatile than average (for this exchange).
| Revenue TTM | US$43.4 billion |
|---|---|
| Operating margin TTM | 18.43% |
| Gross profit TTM | US$19 billion |
| Return on assets TTM | 4.95% |
| Return on equity TTM | 13.28% |
| Profit margin | 13.68% |
| Book value | 117.317 |
| Market capitalisation | US$189.6 billion |
TTM: trailing 12 months
Dividend payout ratio: 6.58% of net profits
Recently Thermo Fisher Scientific has paid out, on average, around 6.58% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Thermo Fisher Scientific shareholders could enjoy a 0.29% return on their shares, in the form of dividend payments. In Thermo Fisher Scientific's case, that would currently equate to about $1.35 per share.
While Thermo Fisher Scientific's payout ratio might seem low, this can signify that Thermo Fisher Scientific is investing more in its future growth.
Thermo Fisher Scientific's most recent dividend payout was on 16 January 2024. The latest dividend was paid out to all shareholders who bought their shares by 14 December 2023 (the "ex-dividend date").
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Thermo Fisher Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 14.69
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Thermo Fisher Scientific's overall score of 14.69 (as at 01/01/2019) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Thermo Fisher Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 2.11/100
Thermo Fisher Scientific's environmental score of 2.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 6.69/100
Thermo Fisher Scientific's social score of 6.69 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 3.38/100
Thermo Fisher Scientific's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Thermo Fisher Scientific scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Thermo Fisher Scientific has, for the most part, managed to keep its nose clean.
Thermo Fisher Scientific Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 14.69 |
|---|---|
| Total ESG percentile | 14.7 |
| Environmental score | 2.11 |
| Environmental score percentile | 1 |
| Social score | 6.69 |
| Social score percentile | 1 |
| Governance score | 3.38 |
| Governance score percentile | 1 |
| Level of controversy | 2 |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Looking for the best performing stocks in Australia? We update this list weekly.
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Steps to owning and managing Microsoft shares from in Australia.
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Learn about the money market and everyday consumer money market products.
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
Follow these tips to find the best share trading platform for you.
